trending Market Intelligence /marketintelligence/en/news-insights/trending/w29eaIVNpVNnvVZBx3WQ_g2 content esgSubNav
In This List

Fitch affirms Allergan's issuer default rating

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Fitch affirms Allergan's issuer default rating

Fitch Ratings affirmed the BBB- issuer default rating of Allergan plc.

The rating agency also affirmed and withdrew the BBB- issuer default ratings of Allergan's units Warner Chilcott Ltd. and Allergan Finance LLC as they are no longer considered by Fitch to be relevant to its coverage.

The outlook on the ratings is stable.

Fitch said the rating reflects the smaller and less diversified nature of Allergan's operating profile relative to larger innovative pharmaceutical industry peers Pfizer Inc. and Merck & Co. Inc. This is particularly evident regarding scale, breadth, depth and patent risk.